Zurich Insurance Group Ltd FI increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 14.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 60,921 shares of the company’s stock after buying an additional 7,599 shares during the period. Zurich Insurance Group Ltd FI’s holdings in Cardinal Health were worth $4,747,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in Cardinal Health by 1.9% in the second quarter. Vanguard Group Inc. now owns 23,642,277 shares of the company’s stock valued at $1,842,205,000 after buying an additional 440,967 shares in the last quarter. BlackRock Inc. raised its position in shares of Cardinal Health by 6.5% in the second quarter. BlackRock Inc. now owns 22,843,418 shares of the company’s stock worth $1,779,958,000 after acquiring an additional 1,398,496 shares during the period. State Street Corp raised its position in shares of Cardinal Health by 1.1% in the first quarter. State Street Corp now owns 16,790,201 shares of the company’s stock worth $1,369,247,000 after acquiring an additional 176,331 shares during the period. Franklin Resources Inc. raised its position in shares of Cardinal Health by 72.1% in the second quarter. Franklin Resources Inc. now owns 6,283,529 shares of the company’s stock worth $489,613,000 after acquiring an additional 2,632,836 shares during the period. Finally, FMR LLC raised its position in shares of Cardinal Health by 47.1% in the first quarter. FMR LLC now owns 5,915,289 shares of the company’s stock worth $482,391,000 after acquiring an additional 1,895,089 shares during the period. Institutional investors own 87.98% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Cardinal Health, Inc. (CAH) Position Increased by Zurich Insurance Group Ltd FI” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/02/cardinal-health-inc-cah-position-increased-by-zurich-insurance-group-ltd-fi.html.

Shares of Cardinal Health, Inc. (CAH) traded up 1.70% during mid-day trading on Monday, hitting $68.06. The company had a trading volume of 393,609 shares. Cardinal Health, Inc. has a 12 month low of $62.70 and a 12 month high of $84.88. The firm has a 50-day moving average price of $67.69 and a 200 day moving average price of $74.72. The firm has a market capitalization of $21.54 billion, a P/E ratio of 16.89 and a beta of 0.86.

Cardinal Health (NYSE:CAH) last issued its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The company had revenue of $32.97 billion for the quarter, compared to analyst estimates of $32.73 billion. During the same period in the prior year, the business posted $1.14 earnings per share. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, equities research analysts forecast that Cardinal Health, Inc. will post $4.95 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be given a dividend of $0.4624 per share. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.76%. Cardinal Health’s payout ratio is 45.79%.

Several equities research analysts have recently issued reports on the stock. Vetr raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 target price on the stock in a research note on Tuesday, June 13th. BidaskClub lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 11th. Zacks Investment Research upgraded Cardinal Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 20th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $77.00 price target on shares of Cardinal Health in a report on Thursday, July 27th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cardinal Health in a report on Sunday, September 10th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $76.81.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.